Industry committee  We compare ourselves a lot to Europe, given the agreement negotiations that are under way. Europe does not have patent-linkage regulations. This is basically a system that allows generic manufacturers to have access to patented research from companies. However, as soon as generic

Industry committee  First, we have to establish what “innovation” means. This word can have various meanings. If we talk about innovation in terms of economic performance, we can say that economic performance went up until the mid-1990s. But if we talk about therapeutic innovation in the pharmaceuti

Industry committee  If it is okay with everyone, I'm going to present in English. I think it will be easier. I'm going to be discussing policies to encourage innovative R and D in the Canadian pharmaceutical industry and basically show how these innovation policies right now are very costly and als